Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklas Hauptstein

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 12, 2022
Bioconjugation strategies and clinical implications of Interferon-bioconjugatesNiklas Hauptstein, Lorenz Meinel, Tessa Lühmann
Journal of Pharmaceutical Sciences|November 3, 2021
Linear Polyglycerol for N-terminal-selective Modification of Interleukin-4Michael Tully, Niklas Hauptstein, Kai Licha, et al.
Bioconjugate Chemistry|December 30, 2021
Chemo-Enzymatic PEGylation/POxylation of Murine Interleukin-4Dorothee Haas, Niklas Hauptstein, Michael Dirauf, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 30, 2022
Merging bioresponsive release of insulin-like growth factor I with 3D printable thermogelling hydrogelsMatthias Beudert, Lukas Hahn, Anselm H C Horn, et al.
ACS Biomaterials Science & Engineering|January 13, 2021
Supramolecular Threading of Peptide Hydrogel FibrilsNiklas Hauptstein, Luis M De Leon-Rodriguez, Alok K Mitra, et al.
Angewandte Chemie (International Ed. in English)|January 9, 2025
Deciphering Polymer Interactions in Bioconjugates with Different Architectures by Structural Analysis via Time-Resolved Limited Proteolysis Mass SpectrometryPrisca Hamm, Marc D Driessen, Niklas Hauptstein, et al.
Biomacromolecules|October 13, 2021
Molecular Insights into Site-Specific Interferon-α2a Bioconjugates Originated from PEG, LPG, and PEtOxNiklas Hauptstein, Paria Pouyan, Josef Kehrein, et al.
Biomacromolecules|July 29, 2022
PEtOxylated Interferon-α2a Bioconjugates Addressing H1N1 Influenza A Virus InfectionNiklas Hauptstein, Michael Dirauf, Kevin Wittwer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 28, 2022
Polymer selection impacts the pharmaceutical profile of site-specifically conjugated Interferon-α2aNiklas Hauptstein, Paria Pouyan, Kevin Wittwer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 12, 2022
Bioconjugation strategies and clinical implications of Interferon-bioconjugatesNiklas Hauptstein, Lorenz Meinel, Tessa Lühmann
Journal of Pharmaceutical Sciences|November 3, 2021
Linear Polyglycerol for N-terminal-selective Modification of Interleukin-4Michael Tully, Niklas Hauptstein, Kai Licha, et al.
Bioconjugate Chemistry|December 30, 2021
Chemo-Enzymatic PEGylation/POxylation of Murine Interleukin-4Dorothee Haas, Niklas Hauptstein, Michael Dirauf, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 30, 2022
Merging bioresponsive release of insulin-like growth factor I with 3D printable thermogelling hydrogelsMatthias Beudert, Lukas Hahn, Anselm H C Horn, et al.
ACS Biomaterials Science & Engineering|January 13, 2021
Supramolecular Threading of Peptide Hydrogel FibrilsNiklas Hauptstein, Luis M De Leon-Rodriguez, Alok K Mitra, et al.
Angewandte Chemie (International Ed. in English)|January 9, 2025
Deciphering Polymer Interactions in Bioconjugates with Different Architectures by Structural Analysis via Time-Resolved Limited Proteolysis Mass SpectrometryPrisca Hamm, Marc D Driessen, Niklas Hauptstein, et al.
Biomacromolecules|October 13, 2021
Molecular Insights into Site-Specific Interferon-α2a Bioconjugates Originated from PEG, LPG, and PEtOxNiklas Hauptstein, Paria Pouyan, Josef Kehrein, et al.
Biomacromolecules|July 29, 2022
PEtOxylated Interferon-α2a Bioconjugates Addressing H1N1 Influenza A Virus InfectionNiklas Hauptstein, Michael Dirauf, Kevin Wittwer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 28, 2022
Polymer selection impacts the pharmaceutical profile of site-specifically conjugated Interferon-α2aNiklas Hauptstein, Paria Pouyan, Kevin Wittwer, et al.
Pageof 1